In addition, a multivariate analysis indicated that an advanced UICC-stage and high CIP2A expression (CIP2A above median and CIP2A expression used as a continuous marker) were independent prognostic factors for poor outcome in patients with colon cancer (Table 2). This evidence concerns the gene CIP2A and malignant colon neoplasm.